AAAAAA

   
Results: 1-8 |
Results: 8
PRAVASTATIN IN DIABETES-ASSOCIATED HYPERCHOLESTEROLEMIA
Authors: RUSTEMEIJER C SCHOUTEN JA JANSSENS ENW SPOOREN PFMJ VANDOORMAAL JJ
Citation: C. Rustemeijer et al., PRAVASTATIN IN DIABETES-ASSOCIATED HYPERCHOLESTEROLEMIA, Acta diabetologica, 34(4), 1997, pp. 294-300
URINARY ALBUMIN EXCRETION RATE DURING ANGIOTENSIN-II INFUSION IN MICROALBUMINURIC PATIENTS WITH INSULIN AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: SPOOREN PFMJ GANS ROB ADER HJ VERMES I DONKER AJM
Citation: Pfmj. Spooren et al., URINARY ALBUMIN EXCRETION RATE DURING ANGIOTENSIN-II INFUSION IN MICROALBUMINURIC PATIENTS WITH INSULIN AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Nephrology, dialysis, transplantation, 12(2), 1997, pp. 281-285
POSSIBLE INCREASED RISK OF RHABDOMYOLYSIS DURING CONCOMITANT USE OF SIMVASTATIN AND GEMFIBROZIL
Authors: VANPUIJENBROEK EP DUBUFVEREIJKEN PWG SPOOREN PFMJ VANDOORMAAL JJ
Citation: Ep. Vanpuijenbroek et al., POSSIBLE INCREASED RISK OF RHABDOMYOLYSIS DURING CONCOMITANT USE OF SIMVASTATIN AND GEMFIBROZIL, Journal of internal medicine, 240(6), 1996, pp. 403-404
CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA
Authors: BONER G VANDYK DJ TAN MH TAN J EKSTRAND A KOIVISTO VA GROOP LC GROOP PH LUCAS A ROMERO R SALINAS I SANMARTI A ESCOBAR F ESCOBARJIMENEZ F CAMPOSPASTOR MM MUGOZ M GOMEZ M MANGILI R POZZA G SPOTTI D HANSEN KW CHRISTIANSEN JS KLEIN F MOGENSEN CE ZIEKENHUIS M VANDOORN LG SPOOREN PFMJ CRUICKSHANK JK JERVELL J PAUS PN BARNES DJ COLLINS A VIBERTI GC WILLIAMS G NELSTROP GA AMOROSA L ANOLIK JR ARONOFF SL EUBANK B BAILIE M PELLETIER L BLEVINS T CHARLES MA PERRY M CLARKE D TOMKEY D EINHORN D HUMPHRIES D GARBER AJ HAAG B WILLIAMS E HOY W WATKINS M KAHKONEN D KRUGER D KILO C LAFFEL L GOLDEN E LODEWICK P LOVINSKY D MASON J JOHNSON S MCGILL J SCHMIDT L ORLANDER P SORENSON K RASKIN P HELLENBRAND D ROSENBLATT S SCHWARTZ S AUFIERI J SHEEHAN JP ULCHAKER M SKYLER JS AGRAMONTE R STARR J GAGLIASTRE D TAYLOR T DAWN K WARD WK RIGDON M COOPER M GANS DJ
Citation: G. Boner et al., CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(5), 1996, pp. 587-593
EFFECT OF CAPTOPRIL ON PROGRESSION TO CLINICAL PROTEINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND MICROALBUMINURIA
Authors: VIBERTI G MOGENSEN CE GROOP LC PAULS JF BONER G VANDYK DJ LUCAS A ROMERO R SALINAS I SANMARTI A BLOMQVIST AC EKSTRAND A KIRSI VL KOIVISTO VA GROOP LC GROOP PH ESCOBAR F JIMENEZ FE CAMPOSPASTOR MM MUNOZ M GOMEZ M MANGILI R POZZA G SPOTTI D HANSEN KW CHRISTIANSEN JS KLEIN F MOGENSEN CE VANDOORN LG SPOOREN PFMJ CRUICKSHANK JK JERVELL J PAUS PN COLLINS A WILLIAMS G
Citation: G. Viberti et al., EFFECT OF CAPTOPRIL ON PROGRESSION TO CLINICAL PROTEINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND MICROALBUMINURIA, JAMA, the journal of the American Medical Association, 271(4), 1994, pp. 275-279
ENDOTHELIN - A POSSIBLE ROLE IN THE OCCURRENCE OF RENAL-FAILURE IN THROMBOTIC THROMBOCYTOPENIC PURPURA
Authors: SPOOREN PFMJ VERMES I KIP L HAANEN C
Citation: Pfmj. Spooren et al., ENDOTHELIN - A POSSIBLE ROLE IN THE OCCURRENCE OF RENAL-FAILURE IN THROMBOTIC THROMBOCYTOPENIC PURPURA, Thrombosis and haemostasis, 69(4), 1993, pp. 401-402
SIMILAR ALTERATIONS OF LYMPHOCYTE SUBPOPULATIONS IN TYPE-I AND TYPE-II DIABETES
Authors: SPOOREN PFMJ VERMES I SOONS JWPH
Citation: Pfmj. Spooren et al., SIMILAR ALTERATIONS OF LYMPHOCYTE SUBPOPULATIONS IN TYPE-I AND TYPE-II DIABETES, Netherlands journal of medicine, 42(5-6), 1993, pp. 163-167
IN ADDITION TO VONWILLEBRAND-FACTOR AND URINARY ALBUMIN EXCRETION, PLASMA ENDOTHELIN IS AN INDICATOR OF ENDOTHELIAL DYSFUNCTION IN DIABETES-MELLITUS
Authors: VERMES I SPOOREN PFMJ KALSBEEKBATENBURG EM HAANEN C
Citation: I. Vermes et al., IN ADDITION TO VONWILLEBRAND-FACTOR AND URINARY ALBUMIN EXCRETION, PLASMA ENDOTHELIN IS AN INDICATOR OF ENDOTHELIAL DYSFUNCTION IN DIABETES-MELLITUS, Diabetologia, 36(5), 1993, pp. 472-473
Risultati: 1-8 |